Polygenic risk for Alzheimer's disease is associated with neuroaxonal damage before onset of clinical symptoms

Abstract INTRODUCTION Establishing valid diagnostic strategies is a precondition for successful therapeutic intervention in Alzheimer's disease (AD). METHODS One hundred forty‐four healthy 75‐year‐old participants from the Vienna‐Transdanube‐Aging longitudinal cohort study were tested for neuroaxona...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Sonja M. Kagerer, Swapnil Awasthi, Stephan Ripke, Aleksandra Maceski, Pascal Benkert, Aïda B. Fall, Peter Riederer, Peter Fischer, Susanne Walitza, Edna Grünblatt, Jens Kuhle, Paul G. Unschuld
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Wiley 2024-01-01
Saila:	Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Gaiak:	Alzheimer's disease genome‐wide association studies neurofilament light chain plasma biomarker polygenic risk score single molecular array
Sarrera elektronikoa:	https://doi.org/10.1002/dad2.12504
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!